|
HRMakers |
À¯¸í ¿Ü±¹°è ÀÇ·áÀåºñ ȸ»çÀÇ RA ÆÀÀå
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
8³â¡è |
ä¿ë½Ã |
06.01 |
|
|
(ÁÖ) ³Ø½ºÆ®¼¿·º¼Ç |
Technical Development Manager
¼¿ï ÀüÁö¿ª | ´ëÇпø(¼®»ç) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
8³â¡è |
ä¿ë½Ã |
04.28 |
|
|
PPD Korea |
[PPD] ä¿ë°ø°í - Principal Regulatory Affairs Specialist
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
8³â¡è |
ä¿ë½Ã |
03.03 |
|
|
Allergan Korea |
Assistant Manager, Market Access
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
7³â¡è |
ä¿ë½Ã |
11.11 |
|
|
(ÁÖ)¹ÙÀÌÄ¿¸®¾î |
¿Ü±¹°è Á¦¾à ±â¾÷]Licensing
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
¶óÀ̼¾½ºIn/Out |
7³â¡è |
ä¿ë½Ã |
05.06 |
|
|
(ÁÖ)·çÆ®·Î´Ð |
Á¦Ç°±â¼úÆÀ Á¦¾î ´ã´çÀÚ ¸ðÁý
°æ±â °í¾ç½Ã ´ö¾ç±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
7³â¡è |
ä¿ë½Ã |
07.27 |
|
|
HR HONORS |
Pricing & Reimbursement Manager - ¼¼°èÀûÀÎ ¿Ü±¹°è Á¦¾à»ç
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
7³â¡è |
ä¿ë½Ã |
02.14 |
|
|
±¹Á¦¹é½Å¿¬±¸¼Ò |
Research Assistant (PER) ¸ðÁý
¼¿ï °ü¾Ç±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
7³â¡è |
ä¿ë½Ã |
07.04 |
|
|
±¹Á¦¹é½Å¿¬±¸¼Ò |
Associate Research Scientist (PER) ¸ðÁý
¼¿ï °ü¾Ç±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
7³â¡è |
ä¿ë½Ã |
07.04 |
|
|
ºê·¹ÀÎÇãºê |
Global Medical Device ȸ»ç-RA Manager(Â÷Àå±Þ) ä¿ë
¼¿ï ¿µµîÆ÷±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
7³â¡è |
ä¿ë½Ã |
09.23 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Senior CRA II (Regional Lead Role)
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
ä¿ë½Ã |
03.29 |
|
|
½Ã¹ÍÄÚ¸®¾Æ |
[½Ã¹ÍÄÚ¸®¾Æ] Associate Clinical Operations Manager
¼¿ï °³²±¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
»ó½Ãä¿ë |
09.14 |
|
|
ÁÖ½Äȸ»ç Ç층½º |
Àӻ󿬱¸º»ºÎ DMÆÀ ÆÀÀå ä¿ë(Â÷Àå±Þ ÀÌ»ó)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
STAT/DM |
7³â¡è |
ä¿ë½Ã |
08.10 |
|
|
(ÁÖ)À¯À¯Á¦¾à |
°³¹ßÆÀ °æ·ÂÁ÷ ¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
6³â¡è |
ä¿ë½Ã |
02.02 |
|
|
(ÁÖ)À¯À¯Á¦¾à |
ºÐ¼®¿¬±¸ÆÀ °æ·ÂÁ÷ ¸ðÁý
°æ±â ¼ö¿ø½Ã ¿µÅ뱸 | ´ëÇпø(¼®»ç) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
6³â¡è |
ä¿ë½Ã |
02.23 |
|